Related Experiment Video
Updated: May 19, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
AATF/Che-1 acts as a phosphorylation-dependent molecular modulator to repress p53-driven apoptosis
Katja Höpker1, Henning Hagmann, Safiya Khurshid
1Department II of Internal Medicine, University Hospital of Cologne, Cologne, Germany.
Abstract:
Following genotoxic stress, cells activate a complex signalling network to arrest the cell cycle and initiate DNA repair or apoptosis. The tumour suppressor p53 lies at the heart of this DNA damage response. However, it remains incompletely understood, which signalling molecules dictate the choice between these different cellular outcomes. Here, we identify the transcriptional regulator apoptosis-antagonizing transcription factor (AATF)/Che-1 as a critical regulator of the cellular outcome of the p53 response. Upon genotoxic stress, AATF is phosphorylated by the checkpoint kinase MK2. Phosphorylation results in the release of AATF from cytoplasmic MRLC3 and subsequent nuclear translocation where AATF binds to the PUMA, BAX and BAK promoter regions to repress p53-driven expression of these pro-apoptotic genes. In xenograft experiments, mice exhibit a dramatically enhanced response of AATF-depleted tumours following genotoxic chemotherapy with adriamycin. The exogenous expression of a phospho-mimicking AATF point mutant results in marked adriamycin resistance in vivo. Nuclear AATF enrichment appears to be selected for in p53-proficient endometrial cancers. Furthermore, focal copy number gains at the AATF locus in neuroblastoma, which is known to be almost exclusively p53-proficient, correlate with an adverse prognosis and reduced overall survival. These data identify the p38/MK2/AATF signalling module as a critical repressor of p53-driven apoptosis and commend this pathway as a target for DNA damage-sensitizing therapeutic regimens.
Insights
The apoptosis-antagonizing transcription factor (AATF) regulates cell fate after DNA damage. Phosphorylated AATF prevents p53-driven apoptosis, enhancing chemotherapy resistance in tumors.
Area of Science:
- Cellular biology
- Molecular oncology
- Signal transduction
Background:
- Genotoxic stress triggers cell cycle arrest and DNA repair or apoptosis.
- The tumor suppressor p53 is central to the DNA damage response.
- Signaling molecules determining cell fate after DNA damage are not fully understood.
Purpose of the Study:
- Identify critical regulators of the p53 response outcome.
- Investigate the role of apoptosis-antagonizing transcription factor (AATF)/Che-1 in DNA damage response.
- Determine the therapeutic potential of targeting the p38/MK2/AATF pathway.
Main Methods:
- Investigated AATF phosphorylation by MK2 upon genotoxic stress.
- Examined AATF nuclear translocation and binding to pro-apoptotic gene promoters (PUMA, BAX, BAK).
- Utilized xenograft models, AATF depletion, and phospho-mimicking AATF mutants to assess chemotherapy response.
- Analyzed AATF locus copy number and expression in human cancers (endometrial, neuroblastoma).
Main Results:
- AATF phosphorylation by MK2 releases it from the cytoplasm, leading to nuclear translocation.
- Nuclear AATF represses p53-driven expression of pro-apoptotic genes PUMA, BAX, and BAK.
- AATF depletion enhances tumor response to adriamycin chemotherapy in vivo.
- A phospho-mimicking AATF mutant confers adriamycin resistance.
- Nuclear AATF enrichment is observed in p53-proficient endometrial cancers.
- Focal copy number gains at the AATF locus in neuroblastoma correlate with poor prognosis.
Conclusions:
- The p38/MK2/AATF signaling module critically represses p53-driven apoptosis.
- AATF acts as a key determinant of cellular fate following genotoxic stress.
- The AATF pathway represents a potential therapeutic target for sensitizing tumors to DNA damage-inducing agents.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Caspases
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
